General
South Africa to suspend rollout of AstraZeneca coronavirus vaccine
South Africa was set to suspend the rollout of the AstraZeneca vaccine after trial data showed the jab offered limited protection against mild disease caused by B.1.351, the coronavirus variant first identified in the country.
Key points:
- Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against the South Africa variant
- Vaccine lead researcher Sarah Gilbert said the company expected to have a new jab to cope with the variant by September
- Federal Health Minister Greg Hunt said he was not concerned about vaccine
Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against mild disease caused by the South Africa variant.
But the…
Continue Reading
-
Noosa News20 hours agoWounding investigation, Mooloolaba – Sunshine Coast
-
General19 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
Business16 hours agoCan the Xero share price deliver a 17% return after the US acquisition?
-
Noosa News15 hours agoTwo people charged after Mooloolaba stabbing